Fabry disease in children and the effects of enzyme replacement treatment. - Wikidata - awgldk - TriplyDB

Fabry disease in children and the effects of enzyme replacement treatment.

Fabry disease in children and the effects of enzyme replacement treatment.

http://www.wikidata.org/entity/Q37350401

about

Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group Multi-system disorders of glycosphingolipid and ganglioside metabolism Carboxyl-terminal truncations alter the activity of the human α-galactosidase A Gastrointestinal Symptoms of Patients with Fabry Disease.Altered dynamics of a lipid raft associated protein in a kidney model of Fabry disease Effects of enzyme replacement therapy in Fabry disease--a comprehensive review of the medical literature.Safety of agalsidase alfa in patients with Fabry disease under 7 years.Progressive renal failure despite long-term biweekly enzyme replacement therapy in a patient with Fabry disease secondary to a new α-galactosidase mutation of Leu311Arg (L311R).Fabry disease in infancy and early childhood: a systematic literature review.Fabry disease in children: agalsidase-beta enzyme replacement therapy.Neuropathic pain in children.Therapeutic goals in the treatment of Fabry disease.Mutation identification of Fabry disease in families with other lysosomal storage disorders.Fabry disease

P2860

Q33835524-07C801E8-2672-46BD-8C5F-448CF5B498D3 Q33902037-D8206698-E82B-4BC0-8EE8-5C207A92E409 Q35125851-E1D70FB3-16C8-4742-862E-67C24945D291 Q36529707-8B708E00-2473-4F05-A710-264D1FC03FBF Q37624954-97C9BD90-FBE5-40B4-8719-0949BC36EC9A Q37801828-2D3509E9-8DE2-445C-8522-EF3359A0E965 Q37813149-2804F24B-659E-4994-8132-043221101A88 Q37900900-2F9C37CE-3ADD-455B-87F9-7A37478CC54B Q38252008-64A20C75-E43C-47A9-915E-70FBB9492B0A Q44093757-8194C6C8-C562-41DB-B7CE-633C464CF45E Q44688179-694CF3C7-AB59-4938-881A-72E88C8FAA58 Q50436079-BEBEDB54-B744-4155-86C8-7F17B5BD18B6 Q50795517-56AE8898-70FD-49B9-87B5-414980995E7C Q56905945-8363443C-0F29-42D1-A580-82BAF42E4DE2

P2860

Fabry disease in children and the effects of enzyme replacement treatment.

http://www.wikidata.org/entity/Q37350401

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Fabry disease in children and the effects of enzyme replacement treatment.

@en

Fabry disease in children and the effects of enzyme replacement treatment.

@nl

type

label

Fabry disease in children and the effects of enzyme replacement treatment.

@en

Fabry disease in children and the effects of enzyme replacement treatment.

@nl

prefLabel

Fabry disease in children and the effects of enzyme replacement treatment.

@en

Fabry disease in children and the effects of enzyme replacement treatment.

@nl

P1433

Q37350401-D22651CD-C61C-44EB-99C1-E1F4EA1460F6

P1476

Q37350401-3C900258-9C5D-4ABE-B1D9-76D76C5E3BDF

P2093

Q37350401-578F87E8-DDA1-4E4E-8EBD-72D7F4C4153C

P2860

Q37350401-0046F337-6735-408C-8836-A1C68AAC7FAE

Q37350401-04A4CD0C-520F-43CC-A32A-D1C579AFB5CA

Q37350401-0861EC23-15C2-4D6E-A2E6-AE7243A6A0D3

Q37350401-124C00B8-FB99-4C15-8DA7-44438BF49ABD

Q37350401-135CF1A4-B7E8-4D5D-B014-8CE37A9C1557

Q37350401-161F5D28-4D76-41A9-93D6-E6870E1684E2

Q37350401-193D4258-A0D3-42D7-BE16-A59E1B7266CB

Q37350401-1A838018-30D9-40DE-AA1A-251A030C1459

Q37350401-1AAD8BFE-B8A0-4BB8-A94E-18FFB1D77F70

Q37350401-1B9E7D56-F685-4148-BFB3-6726D12A8D07

P2888

Q37350401-F1B6D6D8-2471-44B8-94B4-5FF139CD42F0

P304

Q37350401-AB222743-59DF-429F-9763-7B51CB8DD1D9

P31

Q37350401-9CE0057D-1F4F-4735-80F9-63335FAF5687

P356

Q37350401-48E892C3-1618-4693-8D51-0FED2CAAA419

P433

Q37350401-4D301D19-E97F-4DE3-B6ED-FCF7AF4649BF

P478

Q37350401-265D8128-0704-44EF-A39F-84AF036799FD

P50

Q37350401-C0D1FDFD-F30A-495A-849F-8C8C658A090C

P577

Q37350401-8CF07540-107D-43BA-8327-ACEDD970B3AF

P5875

Q37350401-0E2CA19B-A7EC-48BC-BC9D-B8BE8C1FD624

P698

Q37350401-E9C8CB86-5D0D-43DE-8DA3-C6A328114922

P932

Q37350401-472B47C5-15E1-4BCE-8C9C-C99C544579C0

P356

S00431-009-0937-9

P1433

European Journal of Pediatrics

P1476

Fabry disease in children and the effects of enzyme replacement treatment

@en

P2093

Michael Beck

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term safety and efficacy of enzyme replacement therapy for Fabry disease

Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients.

Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey).

Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey.

Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease.

X-chromosome inactivation.

Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

Neuropathic pain in Anderson-Fabry disease: pathology and therapeutic options.

Renal pathological changes in Fabry disease.

P2888

s00431-009-0937-9

P304

1355-1363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00431-009-0937-9

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P50

Guillem Pintos-Morell

P577

2009-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24040014

http://www.w3.org/2001/XMLSchema#string

P698

19242721

http://www.w3.org/2001/XMLSchema#string

P932

2745529

http://www.w3.org/2001/XMLSchema#string